Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer

被引:18
作者
Trombino, S
Neri, M
Puntoni, R
Angelini, C
Loprevite, M
Cesario, A
Granone, P
Imperatori, A
Dominioni, L
Ardizzoni, A
Filiberti, R
Russo, P
机构
[1] Natl Canc Inst, Dept Integrated Med Oncol DOMI, Unit Translat Res B Lung Canc, I-146132 Genoa, Italy
[2] Natl Canc Inst, Dept Integrated Med Oncol DOMI, Unit Epidemiol & Biostat, I-146132 Genoa, Italy
[3] Natl Canc Inst, Dept Integrated Med Oncol DOMI, Unit Med Oncol A, I-146132 Genoa, Italy
[4] Natl Canc Inst, Dept Integrated Med Oncol DOMI, Unit Mol Epidemiol, I-146132 Genoa, Italy
[5] Univ Genoa, Dept Biol, I-16126 Genoa, Italy
[6] Univ Cattolica Sacro Cuore, Gen Thorac Surg, I-00168 Rome, Italy
[7] Insubria Univ, Unit Thorac Surg, Varese, Italy
[8] Hosp Parma, Unit Med Oncol, Parma, Italy
[9] IRCCS, Translat & Clin Resp Pathol Lab, Rome, Italy
关键词
D O I
10.1373/clinchem.2004.043976
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:1313 / 1314
页数:2
相关论文
共 13 条
[1]  
Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021
[2]   K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease [J].
Borchers, R ;
Heinzlmann, M ;
Zahn, R ;
Witter, K ;
Martin, K ;
Loeschke, K ;
Folwaczny, C .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (06) :715-718
[3]   Comment on "Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-call lung cancer patients" (Cancer Letters 2003;193:207-216) [J].
Gautschi, O ;
Ziegler, A .
CANCER LETTERS, 2004, 204 (01) :1-1
[4]   Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease [J].
Heinzlmann, M ;
Lang, SM ;
Neynaber, S ;
Reinshagen, M ;
Emmrich, J ;
Stratakis, DF ;
Heldwein, W ;
Wiebecke, B ;
Loeschke, K .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (10) :1061-1066
[5]   K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer [J].
Hiyama, T ;
Haruma, K ;
Kitadai, Y ;
Masuda, H ;
Miyamoto, M ;
Tanaka, S ;
Yoshihara, M ;
Shimamoto, F ;
Chayama, K .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) :562-566
[6]   Stimulated human leukocytes cause activating mutations in the K-ras protooncogene [J].
Jackson, JH ;
Vollenweider, M ;
Hill, J ;
Rodriguez, H ;
Schwabacher, AW ;
Mitra, G ;
Kuo, CY .
ONCOGENE, 1997, 14 (23) :2803-2808
[7]   Topographic analysis of K-ras mutations in histologically normal lung tissues and tumours of lung cancer patients [J].
Keohavong, P ;
Mady, HH ;
Gao, WM ;
Siegfried, JM ;
Luketich, JD ;
Melhem, MF .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :235-241
[8]   Inhaled particles and lung cancer. Part A: Mechanisms [J].
Knaapen, AM ;
Borm, PJA ;
Albrecht, C ;
Schins, RPF .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (06) :799-809
[9]   Somatic mutation screening: Identification of individuals harboring K-ras mutations with the use of plasma DNA [J].
Kopreski, MS ;
Benko, FA ;
Borys, DJ ;
Khan, A ;
McGarrity, TJ ;
Gocke, CD .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11) :918-923
[10]   K-ras gene point mutation in neogenetic lesions of subpleural fibrotic lesions: Either an early genetic event in lung cancer development or a non-specific genetic change during the inflammatory reparative process [J].
Maeshima, AM ;
Maeshima, A ;
Kawashima, O ;
Nakajima, T .
PATHOLOGY INTERNATIONAL, 1999, 49 (05) :411-418